FLGT(Fulgent Genetics, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $992.58M | $618.97M | $289.21M | $283.47M | $322.67M |
| 毛利润 | $777.05M | $366.90M | $104.46M | $107.22M | $130.88M |
| 营业利润 | $675.95M | $178.53M | −$195.53M | −$73.92M | −$91.10M |
| 净利润 | $507.36M | $143.40M | −$167.82M | −$42.71M | −$60.51M |
| 经营现金流 | $538.58M | $253.52M | $27.00M | $21.06M | −$101.64M |
| 自由现金流 | $514.76M | $234.75M | $4.80M | −$19.25M | −$124.21M |
| 摊薄每股收益 | — | — | — | — | — |